Figure 2.
Liver magnetic resonance imaging (MRI) T2*changes in patients with β-thalassemia major before and after combination therapy with deferiprone and deferasirox.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.